The recall affects more than 10,000 cases distributed across 26 U.S. states. According to the U.S. Food and Drug Administration (FDA), all affected products remained within wholesale distribution centers and were never offered for sale to consumers.
Great Value is Walmart’s in-house brand and is sold across the retailer’s more than 4,600 locations nationwide. The recalled product was manufactured by Oregon-based United States Bakery, one of the licensed producers of Great Value bakery items.
The FDA classified the recall as a Class II event, indicating that any potential health consequences would likely be temporary or medically reversible, while the chance of serious adverse effects is considered remote.
Recall Affects More Than 188,000 Packages Across 26 States
According to the FDA’s recall notice, United States Bakery initiated the action after observing an “oily and sticky substance” on packaging surfaces that come into direct contact with the finished product. The agency did not identify the substance and provided no additional details regarding its composition. The recall covers 10,447 cases of Great Value Hawaiian Roll 4-pack products, equivalent to 188,046 individual packages. The affected item carries the product identifier F63384.
The FDA reported that the recalled rolls were distributed in Alabama, Arkansas, Arizona, California, Florida, Georgia, Illinois, Indiana, Louisiana, Maine, Minnesota, Missouri, Mississippi, North Carolina, Nebraska, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Utah, Virginia, Wisconsin, and Wyoming.
Code information listed in the recall includes Julian codes 116, 119, 120, 127, 134, and 135. The corresponding production dates were April 26, April 29, April 30, May 7, May 14, and May 15, 2026. According to the FDA, the recall was initiated on May 15, 2026, while the agency assigned its official classification on June 16. The event remains ongoing and has not been terminated.
FDA Says Products Never Reached Consumers
Despite the scale of the recall, the FDA stated that the affected inventory never entered retail distribution. The agency said all recalled products remained at wholesale distribution centers and have been fully accounted for. “This product was never sold in stores and was never available for consumer purchase,” the FDA stated in its report. The agency added that all affected inventory remained under control throughout the recall process.
The recall has been categorized as Class II under the FDA’s three-tier recall system. According to the agency, that designation applies to situations in which exposure to a product may cause temporary or medically reversible health effects, while the likelihood of serious health consequences is considered low.
The FDA’s report identified United States Bakery, based in Eugene, Oregon, as the recalling firm. The company notified consignees through multiple channels, including email, fax, letter, press release, telephone, or in-person visits, according to the agency’s event record.
No press release was issued for the recall, and the FDA has not provided further information regarding the unidentified substance that prompted the action. As of the latest update, no additional history or developments have been listed for the product.
